MAUDE Adverse Event Report: SOFRADIM PRODUCTION SAS SYMBOTEX; MESH, SURGICAL, POLYMERIC

Model Number	SYM2015OS
Medical Device Problem Codes	Degraded (1153); Migration or Expulsion of Device (1395); Mechanics Altered (2984); Adverse Event Without Identified Device or Use Problem (2993); Patient Device Interaction Problem (4001); Material Split, Cut or Torn (4008)
Health Effect - Clinical Codes	Abdominal Pain (1685); Adhesion(s) (1695); Emotional Changes (1831); Unspecified Infection (1930); Inflammation (1932); Nausea (1970); Nerve Damage (1979); Pain (1994); Perforation (2001); Scar Tissue (2060); Vomiting (2144); Hernia (2240); Injury (2348); Obstruction/Occlusion (2422); Unspecified Gastrointestinal Problem (4491); Unspecified Tissue Injury (4559)
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
Event or Problem Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a hernia.It was reported that after the implant, the patient experienced abdominal pain and adhesions.Post-operative patient treatment included revision surgery.
Event or Problem Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a hernia.It was reported that after the implant, the patient experienced hernia recurrence, nausea, vomiting, mesh torn, abdominal wall defect, pain, mental pain, scarring, permanent impairment, loss of enjoyment of life, defective mesh, abdominal pain and adhesions.Post-operative patient treatment included revision surgery and mesh removal.
Additional Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
Additional Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
Event or Problem Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of an incisional hernia.It was reported that after the implant, the patient experienced hernia recurrence, nausea, vomiting, mesh torn, abdominal wall defect, pain, mental pain, scarring, permanent impairment, loss of enjoyment of life, defective mesh, abdominal pain and adhesions.Post-operative patient treatment included revision surgery and mesh removal.
Additional Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
Event or Problem Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of an incisional hernia.It was reported that after the implant, the patient experienced hernia recurrence, nausea, vomiting, mesh torn, abdominal wall defect, pain, mental pain, scarring, permanent impairment, loss of enjoyment of life, defective mesh, abdominal pain, failure of mesh, inflammation, infection, nerve damage, disability, small bowel injury, and adhesions.Post-operative patient treatment included revision surgery, lysis of adhesions, and mesh removal.
Additional Manufacturer Narrative
Additional info: a4, b5, b7, h6 (device codes, patient code).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
Event or Problem Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of an incisional hernia.It was reported that after the implant, the patient experienced perforation, stiff mesh, mesh migration, mesh failure to adhere, ruptured bowel, hernia recurrence, nausea, vomiting, mesh torn, abdominal wall defect, pain, mental pain, scarring, permanent impairment, loss of enjoyment of life, defective mesh, abdominal pain, failure of mesh, inflammation, infection, nerve damage, disability, small bowel injury, and adhesions.Post-operative patient treatment included revision surgery, hernia repair, lysis of adhesions, repair of small bowel injury, repair of ruptured bowel, and mesh removal.
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
Event or Problem Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of an incisional hernia.It was reported that after the implant, the patient experienced perforation, stiff mesh, mesh migration, mesh failure to adhere, ruptured bowel, hernia recurrence, nausea, vomiting, mesh torn, abdominal wall defect, pain, mental pain, scarring, permanent impairment, loss of enjoyment of life, defective mesh, abdominal pain, failure of mesh, inflammation, infection, nerve damage, disability, small bowel injury, adhesions, & small bowel obstruction.Post-operative patient treatment included revision surgery, hernia repair, lysis of adhesions, repair of small bowel injury, repair of ruptured bowel, mesh removal, ct scan, partial mesh removal, & fascial closed with some residual mesh.
Additional Manufacturer Narrative
Additional info: a4, b5, b7.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
Event or Problem Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of an incisional hernia.It was reported that after the implant, the patient experienced difficulty bending over and changing positions, perforation, stiff mesh, mesh migration, mesh failure to adhere, ruptured bowel, hernia recurrence, nausea, vomiting, mesh torn, abdominal wall defect, pain, mental pain, scarring, permanent impairment, loss of enjoyment of life, defective mesh, abdominal pain, failure of mesh, inflammation, infection, nerve damage, disability, small bowel injury, adhesions, small bowel obstruction.Post-operative patient treatment included revision surgery, hernia repair, lysis of adhesions, repair of small bowel injury, partial bowel removal, repair of ruptured bowel, mesh removal, ct scan, partial mesh removal, & fascial closed with some residual mesh.
Additional Manufacturer Narrative
Additional information: a4, b5, b7, h6 (removed ime code).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
Event or Problem Description
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of an incisional hernia.It was reported that after the implant, the patient experienced difficulty bending over and changing positions, perforation, stiff mesh, mesh migration, mesh failure to adhere, ruptured bowel, hernia recurrence, nausea, vomiting, mesh torn, abdominal wall defect, pain, mental pain, scarring, permanent impairment, loss of enjoyment of life, defective mesh, abdominal pain, failure of mesh, inflammation, infection, nerve damage, disability, small bowel injury, adhesions, <(>&<)> small bowel obstruction.Post-operative patient treatment included revision surgery, hernia repair, lysis of adhesions, repair of small bowel injury, partial bowel removal, repair of ruptured bowel, mesh removal, ct scan, partial mesh removal, <(>&<)> fascial closed with some residual mesh.

• Brand Name: SYMBOTEX
• Common Device Name: MESH, SURGICAL, POLYMERIC
• Manufacturer (Section D): SOFRADIM PRODUCTION SAS; 116 avenue du formans; trevoux 01600 ; FR 01600
• Manufacturer (Section G): SOFRADIM PRODUCTION SAS; 116 avenue du formans; trevoux 01600 ; FR 01600
• Manufacturer Contact: justin ellis ; 5920 longbow drive; 8200 coral sea st ne; mounds view,mn, CO 55112 ; 7635265677
• MDR Report Key: 10071608
• Report Number: 9615742-2020-01157
• Device Sequence Number: 16801571
• Product Code: FTL
• UDI-Device Identifier: 10884521190467
• UDI-Public: 10884521190467
• Combination Product (Y/N): N
• Initial Reporter State: NY
• Initial Reporter Country: US
• PMA/510(K) Number: K142908
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2015
• Device Explanted Year: 2016
• Serviced by Third Party (Y/N): N
• Reporter Type: Manufacturer
• Report Source: Consumer
• Initial Reporter Occupation: Non-Healthcare Professional
• Type of Report: Initial,Followup,Followup,Followup,Followup
• Report Date (Section B): 04/29/2025

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Expiration Date: 11/30/2016
• Device Model Number: SYM2015OS
• Device Catalogue Number: SYM2015OS
• Device Lot Number: PNL0184X
• Was Device Available for Evaluation?: No
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 05/06/2020
• Supplement Date Received by Manufacturer: 01/26/2022; 02/14/2022; 03/01/2023; 09/25/2024; 11/20/2024; 01/15/2025; 04/23/2025
• Initial Report FDA Received Date: 05/19/2020
• Supplement Report FDA Received Date: 02/14/2022; 03/02/2022; 03/02/2023; 09/26/2024; 12/06/2024; 01/16/2025; 04/29/2025
• Date Device Manufactured: 12/19/2013
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Concomitant Medical Products and Therapy/Usage Dates: UNKNOWN PROTACK TACKERS
• Outcome Attributed to Adverse Event: Required Intervention; Disability
• Patient Sex: Female
• Patient Weight: 100 KG